Dr. Sreedevi Koppisetti Jenigiri, MD

Dr. Jenigiri practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Jenigiri's NPI, 1598930257, was assigned on April 24, 2008. Dr. Jenigiri holds Iowa license MD-41915.

Dr. Jenigiri's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Jenigiri's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Jenigiri is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Jenigiri to 3 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jenigiri practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Jenigiri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Jenigiri's licenses on file in 2 states: Iowa and Louisiana.

CMS data shows 392 Medicare services from Dr. Jenigiri across 3 procedure codes in 2024, all of them office visits, for 188 Medicare patients. Medicare paid $37,557 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Jenigiri in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jenigiri's median patient age at 74, with 50% women.

In 2024, Dr. Jenigiri wrote 698 Medicare Part D claims for 220 patients. 94% of them were for generic drugs. CMS names the drug for 556 of them, across 14 drugs with 11 or more claims each, at $20,114 in total drug cost. In 2023, CMS named 896 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Jenigiri for performance year 2024, reported as part of a group. Dr. Jenigiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jenigiri as offering telehealth.